stress incontinance. stress incontinance
Conditions
Interventions
Intervention 1: Intervention group 1: The orally sustained release drug of Tuliridin (Detrozitol ) 4 mg a day ( once a day) for two months. Intervention 2: Intervention group 2: The oral drug of
Treatment - Drugs
Intervention group 1: The orally sustained release drug of Tuliridin (Detrozitol ) 4 mg a day ( once a day) for two months.
Intervention group 2: The oral drug of ? Sulfiniacin ,4 mg a day ( once a day) for two months.
Sponsors
Vice Chancellor for Research, Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: Age more than 18 years; Urge incontinence; Mixed incontinence; urination in the day more than 8 times and urination in the night more than once; more than once a day with urge incontinence; Sense of urgency to urinate in 24 hours. Exclusion Criteria: Lack of consent to the participation; Contraindications received antimuscarinic drugs such as glaucoma.
Exclusion criteria
Exclusion criteria:
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Drug complication. Timepoint: two month after treatment. Method of measurement: Ask the patient. | — |
Primary
| Measure | Time frame |
|---|---|
| Urinary frequency. Timepoint: Before and two month after treatment. Method of measurement: Specific Questionaire.;Nuctury ( frequency of night urination ). Timepoint: Before and two month after treatment. Method of measurement: Specific Questionaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Maryam Hajhashemy
Pelvic Clinic of Valiasr Hospital
Outcome results
None listed